NHU(SZ:002001) Shenwan Hongyuan Securities·2025-10-29 08:46Investment Rating - The report maintains an "Outperform" rating for the company [2] Core Views - The company reported slightly better-than-expected performance for the first three quarters of 2025, with total revenue of 16.642 billion yuan (yoy +5%) and net profit attributable to shareholders of 5.321 billion yuan (yoy +33%) [7] - The company is leveraging volume to compensate for price declines in vitamins, with a notable increase in liquid egg production contributing to profitability [7] - The vitamin market is showing signs of recovery after a downturn, with expectations of improved profitability due to reduced inventory levels and price stabilization [7] - The company is advancing its new materials projects and expanding into the pesticide market, enhancing its "Chemicals+" and "Biology+" platforms [7] Financial Summary - For 2025, the company is projected to achieve total revenue of 23.936 billion yuan, with a net profit of 6.510 billion yuan, reflecting a growth rate of 10.8% and 10.9% respectively [6] - The gross margin is expected to be 41.2% in 2025, with a return on equity (ROE) of 19.0% [6] - The company's earnings per share (EPS) is forecasted to be 2.12 yuan in 2025, with a price-to-earnings (PE) ratio of 11 [6]